|
1
|
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
|
Blood
|
2009
|
2.24
|
|
2
|
Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein.
|
Nat Biotechnol
|
2009
|
1.59
|
|
3
|
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
|
J Exp Med
|
2009
|
1.34
|
|
4
|
Modulation of dendritic cell differentiation and maturation by decoy receptor 3.
|
J Immunol
|
2002
|
1.20
|
|
5
|
Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).
|
Blood
|
2007
|
1.11
|
|
6
|
Attenuation of Th1 response in decoy receptor 3 transgenic mice.
|
J Immunol
|
2005
|
1.06
|
|
7
|
Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
|
FASEB J
|
2013
|
1.01
|
|
8
|
Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.
|
Cancer Sci
|
2011
|
0.99
|
|
9
|
Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3.
|
Exp Cell Res
|
2004
|
0.95
|
|
10
|
Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.
|
Cell Mol Life Sci
|
2013
|
0.94
|
|
11
|
Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.
|
J Biol Chem
|
2004
|
0.76
|
|
12
|
Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
|
J Immunol
|
2012
|
0.76
|